clinical trial · NCT04736602
Efficacy and Safety Study of Triptorelin 3-Month Formulation in Chinese Children With Central Precocious Puberty.
Ipsen·phase3·completed·n = 32
Central Precocious PubertyTriptorelin pamoate 15mg
brief summary
The purpose of this research was to confirm the effectiveness and safety of the study drug, Triptorelin pamoate 15mg 3-month formulation, in a Chinese population of Central Precocious Puberty (CPP) children.
started
Mar 27, 2021
primary completion
Feb 9, 2022
completion
Sep 3, 2022
last updated
Aug 1, 2024
official title
An Open-label, Multicentre, Single Arm Study to Assess the Efficacy and Safety of Triptorelin 3-month Formulation in Chinese Children With Central Precocious Puberty
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol